siRNA, Anti-F8A1, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT26200WQ-2OMe)

The product SIRGT26200WQ-2OMe is a type of small interfering RNA (siRNA) that targets F8A1 gene and regulates the expression of gene. The siRNA interferes with the expression of F8A1 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_012151.3
Alternative Names DXS522E; F8A; HAP40
Related Diseases Retiform Hemangioendothelioma
Purification HPLC
Target Gene
Gene ID 8263
Uniprot ID P23610
Sub Cat Target Species Modification Scale  
SIRGT27200WQ-2F F8A1 Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT28200WQ-2MOE F8A1 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT29200WQ-LNA F8A1 Human Locked Nucleic Acid (LNA) Inquiry
SIRGT26200WQ-RB F8A1 Human Ribo-modified Inquiry
SIRGT27200WQ-BB F8A1 Human Backbone-modified Inquiry

Related Products